Valuation: BOIRON

Market Cap 477M 545M 440M 407M 771M 51.99B 784M 5.26B 2.06B 25.64B 2.05B 2B 88.12B P/E 2024
41x
P/E 2025 16.1x
Enterprise Value 430M 490M 396M 366M 694M 46.77B 705M 4.74B 1.86B 23.07B 1.84B 1.8B 79.29B EV / Sales 2024
0.85x
EV / Sales 2025 0.95x
Free-Float
19.96%
Yield 2024
4.48%
Yield 2025 4.46%
1 day-1.25%
1 week-1.25%
Current month-1.25%
1 month-1.25%
3 months+5.00%
6 months+5.00%
Current year+5.00%
1 week 31.5
Extreme 31.5
31.5
1 month 31.5
Extreme 31.5
31.5
Current year 31.5
Extreme 31.5
31.9
1 year 24
Extreme 24
32.28
3 years 24
Extreme 24
53.5
5 years 24
Extreme 24
53.5
10 years 24
Extreme 24
99.25
Manager TitleAgeSince
Chief Executive Officer 57 2024-12-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Chairman 65 2011-06-30
Director/Board Member 54 2010-03-09
Director/Board Member 51 2013-05-22
Change 5-day change 1-year change 3-year change Capi.($)
-1.25%-1.25% - - 546M
+0.95%-0.08%-12.82%-8.16% 12.85B
+2.42%+1.37%-33.43%-54.80% 4.79B
-0.02%-0.64%-6.89%-5.76% 4.4B
-7.84%-7.31%+12.48%-9.74% 3.68B
+2.11%-0.70%+4.02%-37.69% 3.82B
-0.58%+6.63%-8.69%-13.03% 3.26B
+0.28%+0.57%-11.39%+2.92% 3.1B
-0.77%+1.24%-7.85%-23.20% 2.41B
-0.32%+4.78%-5.40%+44.70% 1.8B
Average -0.50%-1.14%-7.77%-11.64% 4.46B
Weighted average by Cap. -0.03%-1.26%-9.63%-14.49%

Financials

2024 2025
Net sales 488M 557M 450M 415M 787M 53.08B 800M 5.38B 2.11B 26.18B 2.09B 2.04B 89.98B 501M 572M 462M 427M 809M 54.56B 822M 5.52B 2.17B 26.91B 2.15B 2.1B 92.48B
Net income 11.34M 12.94M 10.46M 9.65M 18.31M 1.23B 18.6M 125M 48.99M 609M 48.56M 47.51M 2.09B 32.64M 37.26M 30.11M 27.8M 52.72M 3.55B 53.57M 360M 141M 1.75B 140M 137M 6.02B
Net Debt -49.74M -56.77M -45.88M -42.36M -80.33M -5.42B -81.63M -548M -215M -2.67B -213M -208M -9.18B -47.86M -54.62M -44.14M -40.76M -77.29M -5.21B -78.54M -528M -207M -2.57B -205M -201M -8.83B
Logo BOIRON
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues. Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin. There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties). BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries. Net sales are distributed geographically as follows: France (43.5%), Europe (24%), North America (27.5%) and other (5%).
Employees
2,499
Date Price Change Volume

Annual profits - Rate of surprise